# HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity

> **NCT01377909** · PHASE1 · TERMINATED · sponsor: **Bader, Ted, M.D.** · enrollment: 20 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** statin

## Key facts

- **NCT ID:** NCT01377909
- **Lead sponsor:** Bader, Ted, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Principal Investigator retiring
- **Last updated:** 2013-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01377909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01377909, "HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01377909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*